Back to Search
ROCHELLE ZAK, M.D.
M.D.
Sleep Medicine (Psychiatry & Neurology) Physician
NPI: 1285606863IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pulmonary Disease Physician
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
176119(NY)
Sleep Medicine (Psychiatry & Neurology) PhysicianPrimary
Psychiatry & Neurology — Sleep Medicine
Code: 2084S0012X
039291(CT)G64567(CA)
Education
OTHER
Class of 1987
Research & Publications (20)
Continuing medical education. Interactive technology enhances instruction for both teacher and learner.
PMID 15311548·Healthc Inform·2004
8-other
Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. An American Academy of Sleep Medicine report.
PMID 18220088·Sleep·2008
6-review
Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivo.
PMID 17181493·Hum Gene Ther·2007
7-preclinical
Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.
PMID 18246980·Sleep·2007
6-review
Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report.
PMID 18041479·Sleep·2007
6-review
Does blood donor history accurately reflect the use of prescription medications? A comparison of donor history and serum toxicologic analysis.
PMID 16934078·Transfusion·2006
8-other
Unique biologic properties of recombinant AAV1 transduction in polarized human airway epithelia.
PMID 16899463·J Biol Chem·2006
7-preclinical
Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
PMID 16149910·Hum Gene Ther·2005
8-other
Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.
PMID 15596830·J Virol·2005
7-preclinical
A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma.
PMID 15585612·Clin Cancer Res·2004
3-trial
Sleep in women across the life cycle from adulthood through menopause.
PMID 15087212·Med Clin North Am·2004
6-review
Targeted correction of single-base-pair mutations with adeno-associated virus vectors under nonselective conditions.
PMID 15047832·J Virol·2004
7-preclinical
Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia.
PMID 14990705·J Virol·2004
7-preclinical
Immunization with live HPV-16-transformed mouse cells expressing the herpes simplex thymidine kinase and either GM-CSF or IL-2.
PMID 12888917·Int J Oncol·2003
7-preclinical
Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia.
PMID 12805434·J Virol·2003
8-other
Sleep in women across the life cycle from adulthood through menopause.
PMID 12628216·Sleep Med Rev·2003
6-review
Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.
PMID 11836382·J Virol·2002
4-observational
Objective evaluation of improvement in optic neuropathy following radiation therapy for thyroid eye disease.
PMID 10758323·Int J Radiat Oncol Biol Phys·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2330 POST ST., #420
SAN FRANCISCO, CA 94115 - Phone
- (415) 885-7886
Quick Facts
- NPI
- 1285606863
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile